Introduction {#s1}
============

Transposons are mobile DNA elements that move or copy their DNA sequence from one location to another. They have exhibited a remarkable ability to spread, such that sequences derived from transposons are pervasive in the genomes of prokaryotes and eukaryotes alike ([@bib5]). Among transposons whose behavior has been examined in vitro, the transposable *Escherichia coli* bacteriophage Mu is one of the most active ([@bib17]; [@bib29]) and well-studied (reviewed in [@bib18]). Its transposase, MuA, belongs to the large DDE family of recombinases ([@bib6]; [@bib37]). This family is named for the amino acid residues in their shared RNase-H-like catalytic domains that bind the divalent metals necessary for catalysis. In addition to the transposases for many common transposons, the DDE family also includes retroviral integrases, which use the same reaction mechanism to integrate viral genomes into host chromatin ([@bib12]; [@bib22]).

To catalyze transposition ([Figure 1A](#fig1){ref-type="fig"}), DDE recombinases like MuA bind specific sequences at each end of their element and synapse them together in a complex known as the transpososome (or, for retroviral integrases, the intasome) ([@bib41]; [@bib43]). The transpososome then hydrolyzes the phosphate backbone at the boundary between the transposon and flanking host DNA, and catalyzes the attack of the resulting 3' hydroxyl groups from each transposon end into the 'target' destination DNA. This critical second chemical step is referred to as strand transfer. In the case of bacteriophage Mu, the entire prophage acts as a transposon, and strand transfer occurs at positions 5 bp apart in the target DNA ([@bib15]). Rather than catalyzing multiple turnovers like a typical enzyme, MuA remains bound to the branched strand transfer products until forcibly disassembled by the ATP-powered host chaperone ClpX ([@bib8]; [@bib27]), after which transposition can be completed by the host's own DNA repair and replication machinery ([@bib30]; [@bib35]). Although MuA is still active after removal by ClpX in vitro, it may be degraded by the ClpXP chaperone-protease complex in vivo ([@bib21]).10.7554/eLife.21777.003Figure 1.Transposition by Bacteriophage Mu and Available Structures of DDE family members.(**A**) Diagram of replicative transposition. The transposable element (here, the phage genome) is in green with transposase binding sites in red and blue. Transposase subunits (here, MuA, in light yellow circles) synapse element ends and catalyze their nicking and subsequent joining to target DNA (black). In vivo, the flanking DNA (grey) is double stranded and may represent the entire host chromosome, which may also provide the target site. (**B**) The in vitro Mu transposition system used here utilizes short linear fragments for both the target DNA and phage ends, with 3 nt of single stranded flanking DNA. (**C**) Strand transfer complex structures. DNA is colored as in (**A**), with protein components partially transparent and colored according to their bound DNA. Generated from PDB IDs 4FCY (Mu), 3OS0 (PFV), 5HOO (Mos1), and 5EJK (RSV).**DOI:** [http://dx.doi.org/10.7554/eLife.21777.003](10.7554/eLife.21777.003)10.7554/eLife.21777.004Figure 1---figure supplement 1.Mu end and target DNA fragments.(**A**) The Mu end DNA fragments used for transposition reactions. The bottom strand becomes joined to the target DNA during strand transfer. The bold red 3' adenine provides the 3' hydroxyl group that is the nucleophile for this reaction. In fluorescence anisotropy and some FRET experiments (where indicated in the text), this adenine lacked a 3' hydroxyl group so as to suppress strand transfer. Blue arrows mark the binding sites for MuA; the R2 binding site is replaced with a binding site for the Sin recombinase in the SinMu system. The Mu end DNA is identical to that used to generate the Mu STC crystal structure ([@bib33]). (**B**) Linear target DNA substrates. The G:G mismatch, when used, was placed in the center of the sequence by replacing a C in the bottom strand with a G, indicated in green. Red arrows mark the position of the predominant strand transfer product when the mismatch is present. The 45 bp target DNA was used in the experiments in [Figure 5](#fig5){ref-type="fig"} to discourage melting of the strand transfer products during heating, and is identical in sequence to the 35 bp target used elsewhere except for 5 bp added at each end. Target DNAs were labeled at the 5' end of the top strand with ^32^P for all radiographic experiments, and with the Atto565 fluorophore for fluorescence anisotropy and FRET. FRET substrates included an additional Atto647N fluorophore at the 5' end of the bottom strand. The 35 bp target (with a mismatched base pair) is also identical to that used to generate the Mu STC crystal structure ([@bib33]).**DOI:** [http://dx.doi.org/10.7554/eLife.21777.004](10.7554/eLife.21777.004)

Transposases and integrases face two challenges when interacting with target DNA sites. First, successful transposition requires that they avoid selecting their own DNA as a target, as intra-self strand transfer can lead to deletion of some or all of the mobile element and a double strand break. To this end, MuA and some other DDE transposases interact with a partner protein whose role is to remain bound only to distant, non-self target sites. For Mu, this is the MuB protein encoded by the phage itself ([@bib26]; [@bib28]), whereas retroviral integrases bind to host nucleosomes to choose a target ([@bib36]). However, the mechanism(s) by which transpososomes resist the high local concentration of self-DNA but are activated to attack DNA bound by their target selection partner are not well understood.

After strand transfer, the transposase must also avoid catalysis of the reverse reaction (termed 'disintegration') in the time before host machinery completes transposition. Strand transfer merely exchanges of one pair of 3' hydroxyl groups and phosphodiester bonds for another and so should not provide a net release of chemical bond energy that could drive the reaction towards its products. Nevertheless, the Mu transpososome displays a strong bias towards catalysis of only the forward strand transfer reaction ([@bib4]; [@bib20]; [@bib32]). It seems likely that this bias stems in some way from product binding energy, as transpososomes remain tightly bound to their products.

Here we show that target DNA bending contributes to overcoming both of the above challenges. Four crystal structures of transpososomes and intasomes from the DDE family that include the target DNA are available, including that of the Mu transpososome ([Figure 1C](#fig1){ref-type="fig"}) ([@bib24]; [@bib33]; [@bib34]; [@bib48]). Beyond the shared catalytic domain fold, the specifics of the protein-protein and protein-DNA contacts in these structures are very different. Nevertheless, they have all converged on a bend in the target DNA following strand transfer. Clues that target DNA bending can play a role in target site selection come from studies of target site preferences. In the absence of target selection partners, Mu and retroviral integrases prefer target sites with more easily deformable sequence steps, suggesting that DNA flexibility is interrogated prior to strand transfer and can guide target site selection ([@bib16]; [@bib36]; [@bib40]). This is supported by a structure of the prototype foamy virus (PFV) intasome bound to, but not integrated into, target DNA, which shows the target DNA bent in a conformation very similar to that in the strand transfer complex ([@bib24]). On the other hand, it has also been suggested that target DNA bending could prevent the reversal of strand transfer by driving the products (the new target 3' hydroxyl group and transposon-target phosphodiester bond) out of the active sites to reduce the conformational strain of the bend ([@bib24]; [@bib33]). Both ideas have yet to be tested directly in vitro.

In this work, we measure how target DNA flexibility and bending affect target DNA binding, strand transfer, and disintegration by the Mu transpososome. We show that increasing DNA flexibility has a dramatic positive effect on the transposition reaction and that bending occurs during binding, implying that bending is required but carries a steep energetic cost. Afterwards, disintegration is very rare and occurs under extreme conditions that coincide with disruption of the bend. Further, a mutant transpososome with compromised target DNA binding and bending can be rescued by pre-bent DNA and is particularly prone to strand transfer reversal. Our results are the first to biochemically link unbending to reversal, and also point to target DNA bending as a key energetic barrier to strand transfer. This barrier would allow DNA deformation generated by other proteins to steer target site selection, and provide a way to channel product binding energy into preventing strand transfer reversal.

Results {#s2}
=======

Flexible or bent DNA is a highly reactive transposition target {#s2-1}
--------------------------------------------------------------

Mu is an attractive model system because transpososomes can be assembled in vitro from MuA protein and short DNA substrates ([Figure 1B](#fig1){ref-type="fig"}) ([@bib39]). The DNAs we use here mimic the products of transposon-host junction cleavage, thus removing that earlier reaction step from our analysis (compare [Figure 1A](#fig1){ref-type="fig"} versus [Figure 1B](#fig1){ref-type="fig"}). They retain only 3 nt of flanking DNA on the non-transferred strand ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).The assembled transpososome without target DNA is referred to as the cleaved-donor complex (CDC), and a transpososome that has bound and attacked target DNA as the strand transfer complex (STC). All MuA constructs used here lacked domain Iα (residues 1--76), a site-specific DNA binding domain which in vivo binds an enhancer sequence within the interior of the Mu genome to aid transpososome assembly ([@bib31]). This domain was also omitted in the crystal structure of the Mu STC ([@bib33]), is not required for transposition in vitro, and is in fact slightly inhibitory in the absence of the enhancer ([@bib47]).

We first sought to determine whether target DNA flexibility has an effect on target DNA binding and the kinetics of the strand transfer reaction. We use two methods to increase the flexibility of duplex DNA: DMSO added to the reaction buffer ([@bib11]; [@bib19]), and/or a single G:G base-pairing mismatch incorporated at the center of the target DNA sequence ([@bib38]). In addition to altering the biophysical properties of DNA, both have been used in previous studies as general enhancers of the transposition activity of MuA in vitro ([@bib7]; [@bib39]; [@bib46]). Because DMSO also affects earlier transpososome assembly steps, and to eliminate spare Mu ends or MuA subunits that could compete with our intended target DNAs, we first purified the CDC form of the transpososome by gel filtration chromatography. To prevent premature catalysis of strand transfer, CDCs were assembled and purified in a buffer containing EDTA and lacking Mg^2+^. A 2:1 mixture of MuA protein to Mu end DNA in this buffer results in a gel filtration peak shifted to a very high molecular weight that we identify as CDCs based on size and near-stoichiometric reactivity with target DNA ([Figure 2](#fig2){ref-type="fig"}).10.7554/eLife.21777.005Figure 2.Target DNA bending during Mu transposition affects strand transfer kinetics.(**A**) Purification of transpososome tetramers constructed in vitro by gel filtration. Full transpososomes (black line) are separable from lower molecular weight complexes Also shown are MuA protein and phage end DNAs alone (dashed lines). The contents of only the tetramer peak were used in our assays here. (**B**) Strand transfer kinetics visualized by denaturing gel electrophoresis and 5'-^32^P-labeled target DNA. Where indicated, the 35 bp target DNA sequence includes a G:G base-pairing mismatch and/or the reaction buffer was supplemented with 15% DMSO. Strand transfer results in cleavage of the labeled strand. (**C**) Quantification of the strand transfer kinetics experiments described in (**B**). The vertical axis represents the fraction of total lane signal present in product band(s). The X-axis is broken between 60 and 120 min to enhance the readability of early timepoints. Error bars represent mean ± standard error of the mean (SEM), n = 4 independent CDC preparations, one of which is shown in (**B**).**DOI:** [http://dx.doi.org/10.7554/eLife.21777.005](10.7554/eLife.21777.005)10.7554/eLife.21777.006Figure 2---figure supplement 1.Minor strand transfer products viewed at high contrast.Pictured are the same radiographic gel images given in [Figure 2B](#fig2){ref-type="fig"}, but with the cropping and contrast modified to highlight minor strand transfer products. Note that the mismatch drives strand transfer to occur predominantly at a single position, which is centered around the mismatch, at the expense of the numerous minor products that result from fully base-paired DNA.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.006](10.7554/eLife.21777.006)10.7554/eLife.21777.007Figure 2---figure supplement 2.Modifying target DNA flexibility or removing domain III do not alter the concerted nature of MuA-catalyzed strand transfer.(**A**) The sequence of the hairpin target DNA fragment used here to detect single ended strand transfer events. This differs from the target DNA used throughout this work ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) only in the addition of the hairpin turn sequence shown in bold. As in that Figure, green indicates the nucleotide position that can be changed to generate a base-pairing mismatch. (**B**) Schematic for the experiment to detect single ended events. Single-ended strand transfer can cleave the 5'-labeled hairpin target DNA to create a novel 58 nt product. (**C**) The same experimental protocol as described for [Figure 2](#fig2){ref-type="fig"} was used with the hairpin target DNA to monitor for single-ended events. A faint 58 nt band for these events appears across all conditions. (**D**) As in (**C**), except Δ domain III CDCs (as in the experiments in [Figure 4](#fig4){ref-type="fig"}) were used. (**E**) Quantification of the images in (**C**) and (**D**). The vertical axis represents the percent of the total radioactivity contained in all bands that exists in the 58 nt single ended product band. Across all conditions, single ended events accumulate rapidly to a level ≤3% of total target DNA and remain nearly constant after 10--20 min of reaction time. Because levels remain constant, we interpret this to be the result of a tiny population of defective MuA protein that is capable of participating in assembly but not strand transfer.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.007](10.7554/eLife.21777.007)

We monitored the effect of DNA flexibility on the kinetics of strand transfer by sampling reactions containing 100 nM each of purified CDC and ^32^P-labeled target DNA as a function of time. In these experiments, the target DNA strand is labeled at the 5' end and becomes cleaved as a result of strand transfer. As has been observed previously ([@bib46]), a mismatched base pair directs the vast majority of strand transfer events to occur centered around it, hence the single dominant product ([Figure 2B](#fig2){ref-type="fig"}). The fully base paired target DNA, which is identical in sequence except for the central nucleotide in one strand, results in two major products (and a number of minor products, see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). It is likely that the major insertion site remains approximately centered even without the mismatched base pair because our 35 bp target DNA is not much larger than the total target DNA binding surface of the CDC.

Increased target DNA flexibility via the G:G mismatch or DMSO significantly enhances the rate of strand transfer ([Figure 2B,C](#fig2){ref-type="fig"}), without perturbing the CDCs' ability to perform concerted strand transfer with both ends ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Using the steepest slope between any two timepoints in [Figure 2C](#fig2){ref-type="fig"} as an estimate of initial rate, the initial rate for the unmodified reaction was about 0.1 µM^−1^ min^−1^, and it required about 40 min to convert 30% of the target DNA into strand transfer product. When the reaction buffer was supplemented with 15% (v/v) DMSO, the initial rate was about 0.8 µM^−1^ min^−1^ and was 30% complete in only 4 min. The mismatch was even more powerful, leading to an initial rate of about 3.0 µM^−1^ min^−1^and 30% completion in about 1 min. The combined effect of both modifications was additive, albeit only marginally (shown most clearly in the 2 and 5 min timepoints in [Figure 2C](#fig2){ref-type="fig"}).

To determine whether accelerated strand transfer rates result from tighter binding to the more flexible target DNA substrates, we used fluorescence anisotropy to measure the affinity of the interaction between purified CDCs and target DNA ([Figure 3A](#fig3){ref-type="fig"}). To measure these values under conditions where the MuA active site and the DNA ionic environment would be as realistic as possible, we performed these experiments in the presence of Mg^2+^. Rather than by withholding divalent metals, we prevented strand transfer by using Mu end DNAs lacking the terminal 3'OH group on the transferred strand, which is the nucleophile for strand transfer ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Binding affinities followed a similar pattern to reaction rates: The K~D~ of CDCs for mismatched target DNA (regardless of DMSO) was about 15 nM, and for fully base paired target DNA with DMSO, about 29 nM. In the case of the mismatched target, good fits to the data required a cooperative binding model with a Hill coefficient of 3.3 (for the mismatch alone) and 2.6 (when combined with DMSO). We suspect this arises from transient CDC disassembly events that become significant at low nanomolar concentrations. Conversely, we were unable to detect enough binding to normal DNA under normal buffer conditions to confidently fit a binding curve, but can visually estimate that K~D~ might lie between 0.5--1 µM. Thus, increasing the flexibility of the target DNA can enhance its affinity for transpososomes by at least 33-fold.10.7554/eLife.21777.008Figure 3.Enhanced flexibility triggers tight target DNA binding.Fluorescence anisotropy measurements of transpososome binding to Atto565-labeled target DNAs. Dots are experimental data, with error bars representing 95% confidence intervals derived from 15 measurements (see Materials and methods). Solid lines represent fits to the data to obtain the K~D~ values indicated in the legends. (**A**) Wild-type transpososomes, (**B**) Δ domain III transpososomes (see [Figure 4A](#fig4){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.21777.008](10.7554/eLife.21777.008)10.7554/eLife.21777.009Figure 3---figure supplement 1.Strand transfer and/or target DNA nicking are blocked by terminating the transferred strand with dideoxy-adenosine.The results of a 1 hr reaction between 200 nM 5'-^32^P-labeled target DNA and a pre-formed transpososome mixture using the indicate protein construct(s). The first two lanes are from reactions in which MuA protein and Mu end DNA were omitted. Across all conditions, the reactions in which the transferred strand of the Mu end DNA ended in a 3' dideoxy-A do not show any evidence of strand transfer or other breaks in the target DNA.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.009](10.7554/eLife.21777.009)

These results indicate that bending or otherwise deforming the target DNA poses a significant energetic barrier to binding target DNA. We also note that the binding and kinetic data do not exactly correspond. For instance, although the mismatch and DMSO produced similar enhancements in target DNA affinity (with K~D~s differing by only two-fold), the mismatch had a much stronger effect on the strand transfer reaction than DMSO (with initial rates differing by about four-fold), even though the kinetic experiments were carried out at 100 nM, above the K~D~s for either of these target interactions. This suggests that there may be additional localized target DNA conformational changes, beyond those that are required for initial binding, that are necessary to properly position the target DNA phosphate backbone in the active site, and that are better facilitated by the mismatch than by DMSO.

MuA domain III participates in target DNA binding and bending {#s2-2}
-------------------------------------------------------------

The high binding affinity of CDCs for flexible target DNA suggests that it must be bent in order to make optimal contacts with the transpososome, and the crystal structure of the Mu STC suggests that domain IIIα, which forms a positively charged alpha helix, stabilizes the bent target DNA conformation. The two copies of domain IIIα from the catalytic MuA subunits pair in the middle of the target DNA U-turn ([Figure 4A](#fig4){ref-type="fig"}), presumably countering the electrostatic repulsion between the two arms of the target DNA, as well as providing additional protein-DNA contacts. To test the importance of domain III in DNA binding, we repeated the above kinetic and binding experiments using CDCs lacking domain III on the catalytic MuA subunits. Note that domain IIIβ, which comprises the C-terminal \~60 residues of MuA, was not included in the crystal structure because is not required for transposition in vitro, but has been included in the constructs used in this work. Although domain III can be removed by truncating MuA constructs at residue 560, transpososome assembly requires domain IIIα to be present on the two MuA subunits not involved in catalysis ([@bib2]). In order to localize truncated subunits only at the catalytic positions, we utilized our 'SinMu' system ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) (see also [@bib23]). SinMu is a chimeric protein in which the sequence-specific DNA binding domains of MuA have been replaced with that of the unrelated Sin recombinase. It can be placed at the non-catalytic positions in the transpososome by a corresponding substitution in the Mu end DNA sequence ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Chimeric 'SinMu'-containing CDCs that include the full MuA C-terminus at all subunit positions behave indistinguishably from wild type CDCs ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), and subsequent truncation of the catalytic subunits' domain III does not hinder assembly and purification ([Figure 4B](#fig4){ref-type="fig"}).10.7554/eLife.21777.010Figure 4.Δ Domain III Transpososomes are rescued by enhanced target DNA bending.(**A**) Domain III from the catalytic MuA subunits is used to make contacts to the bent target DNA. The solid (non-transparent) alpha helices indicated with arrows are the portions domain III resolved in the MuA STC crystal structure. Colors as in [Figure 1C](#fig1){ref-type="fig"}, with MuA active site residues as orange spheres. (**B**) Gel filtration chromatography of Δ domain III CDCs. Moving to the chimeric SinMu system and truncating the catalytic MuA subunits to remove domain III does not hinder formation and subsequent purification of CDCs. (**C**) Strand transfer kinetics visualized by denaturing gel electrophoresis and 5'-^32^P-labeled target DNA, as in [Figure 1D](#fig1){ref-type="fig"} except using Δ domain III transpososomes. Lower panels are the product band(s) from the upper panels at greatly increased contrast. (**D**) Quantification of the strand transfer kinetics experiments described in (**C**). The vertical axis represents the fraction of total lane signal present in product band(s). Error bars represent mean ± SEM, n = 4 CDC preparations, one of which is shown in (**C**). (**E**) Rescue of the strand transfer activity of truncated transpososomes by circular DNAs. ^32^P-labeled Mu ends increase in size as a result of strand transfer. Samples were taken 2 hr after transpososomes were mixed with Mg^2+^ and indicated target DNAs.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.010](10.7554/eLife.21777.010)10.7554/eLife.21777.011Figure 4---figure supplement 1.The SinMu system does not inherently alter interactions with target DNA.(**A**) A molecular model of the SinMu system. We use this to direct removal of domain III to only the catalytic (upper) subunits in the transpososome. Because the DNA binding domains from non-catalytic subunits (circled) do not contact any other component of the transpososome, they can be altered to be specified by an alternate DNA binding domain and DNA sequence from the Sin recombinase. Colors are as in [Figure 1B](#fig1){ref-type="fig"}, with the modeled Sin substitutions in orange. (**B**) Quantification of strand transfer kinetics experiments, performed as described for [Figure 2](#fig2){ref-type="fig"}. Solid lines represent the activity of wild type MuA transpososomes, and are the same data plotted in [Figure 2C](#fig2){ref-type="fig"}. Dashed lines represent SinMu transpososomes in which the catalytic subunits are WT (not truncated), under identical conditions. Error bars represent the mean ± the standard error of the mean (SEM) from four independent time-series. (**C**) Fluorescence anisotropy measurements of target DNA binding. The left panel is the same data as in [Figure 3A](#fig3){ref-type="fig"}. The results of identical experiments performed with SinMu transpososomes are shown in the right panel. Error bars represent 95% confidence intervals derived from five technical replicates of 3 independent concentration series (15 total data points, see Materials and methods).**DOI:** [http://dx.doi.org/10.7554/eLife.21777.011](10.7554/eLife.21777.011)10.7554/eLife.21777.012Figure 4---figure supplement 2.Minicircle target DNA.(**A**) Minicircle DNA was constructed from the two linear DNA fragments shown: Circle A (C--A) and Circle B (C--A). Each piece included an approximately centered high affinity binding site for the DNA bending protein IHF. These fragments end in reciprocal complementary four nt overhangs for annealing and ligation.The C-A fragment was designed to optionally include a G:G base-pairing mismatch at the position indicated by the bold green residues. (**B**) Minicircle target DNA. This is the 126 bp circular target DNA used in [Figure 4](#fig4){ref-type="fig"}. The component linear fragments from (**A**) are indicated. The position of the optional G:G mismatched base pair is marked again in bolded green, and the strand transfer attack positions it would produce are marked again with red arrows. The oblong shape is given for illustrative convenience and is not meant to have any correlation the actual physical conformation of the minicircle DNA molecule.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.012](10.7554/eLife.21777.012)10.7554/eLife.21777.013Figure 4---figure supplement 3.Minicircle rescue of Δ domain III transpososome strand transfer activity is not an artifact of the sequences of the DNAs used to form the minicircles.In these experiments, the Mu end DNA used to form transpososomes was labeled with ^32^P. For each lane, the target DNA substrate, presence of a G:G mismatched base-pair in that substrate, and the presence of DMSO in the reaction buffer are indicated above the images. The left half of the bottom panel is the same image as in [Figure 4E](#fig4){ref-type="fig"}. C-A and C-B target DNAs are the linear fragments that were ligated to form the circular target (given in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}); C-A included the G:G mismatch where indicated. Note that the mismatch-bearing C-A is the only circle component able to rescue Δ domain III strand transfer activity on its own, and only in the presence of DMSO, which is the same behavior as for the primary linear fragment used throughout this work.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.013](10.7554/eLife.21777.013)

We found that CDCs where the catalytic MuA subunits lack domain III ('Δ domain III CDCs') display very little strand transfer activity, except under particular conditions. Rather than just enhancing the reaction, the combination of DMSO and a target base-pairing mismatch were nearly essential for the truncated CDCs to catalyze strand transfer into short linear target DNAs at detectable levels ([Figure 4C,D](#fig4){ref-type="fig"}). The reaction rate is otherwise exceedingly slow (\<1% of input after two hours under the next best condition, the mismatch alone). Measurements of target DNA binding by the truncated CDCs once again followed a similar pattern to strand transfer kinetics: binding was relatively robust when both modifications are present simultaneously (K~D~ ≈ 38 nM), but undetectable otherwise ([Figure 3B](#fig3){ref-type="fig"}). Thus, domain III does indeed provide many of the protein-DNA contacts that are important to capture a target. High target DNA flexibility, however, can make up for the loss of these contacts. This confirms our assertion that the contacts are optimized for bent DNA.

To investigate further the connection between binding and bending, we tested whether the strand transfer activity of the truncated CDCs could be rescued by providing pre-bent DNA for use as a target, rather than the linear DNA fragments used thus far. We generated pre-bent DNA by creating 126 bp DNA minicircles ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Instead of just being more flexible, minicircles should be naturally and permanently held in a bent state. This should provide an even lower energy barrier to bending. Accordingly, we found that minicircle DNAs can rescue the strand transfer activity of Δ domain III CDCs under a number of conditions ([Figure 4E](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). While Δ domain III CDCs generate a substantial amount of strand transfer products into linear DNA only in the presence of both the mismatched base-pair and DMSO, strand transfer into minicircles requires only one or the other. Thus the loss of transpososome-target DNA interactions can be mitigated by pre-bending the DNA. This is also further evidence that DMSO and the base-pairing mismatch allow the DNA to be more easily bent, and that target DNA binding is linked to bending.

Strand transfer reversal only occurs under conditions that would compromise target DNA binding {#s2-3}
----------------------------------------------------------------------------------------------

The strand transfer reaction does not change the overall number or type of covalent bonds, and is entropically unfavorable in that it links together previously separate DNA segments. The free energy landscape of this reaction might thus be expected to favor its reversal (hereafter referred to as 'disintegration'). Nevertheless, our data above show that strand transfer is capable of going nearly to completion ([Figure 2C](#fig2){ref-type="fig"}), indicating that the STC is able to suppress disintegration. Given that Mu transpososomes are not true catalysts (each transpososome catalyzes a single strand transfer reaction, and then remains bound to the reaction products), it is likely that MuA suppresses disintegration by using product binding energy to bias the reaction direction toward the final product complex. Our finding that CDCs bind particularly tightly to artificially flexible DNA, and the observation that strand transfer should make any target DNA more flexible by nicking both strands, led us to investigate the relationship between target DNA conformation and disintegration.

We first wanted to establish the baseline rate at which the STC catalyzes disintegration. Published reports currently differ regarding this rate. It is difficult to address because it requires a starting pool of pure STCs (free of unreacted target DNA, which would be indistinguishable from the product of disintegration), and any purification protocols used must preserve the activity and structure of the STCs. This has been previously approached, to our knowledge, in two ways: (1) forming STCs by mixing MuA, Mu end DNAs and target DNA and Mg^2+^, as was done for crystallization ([@bib33]), then purifying the resulting STCs by electrophoresis in an agarose gel in TBE buffer (which chelates Mg^2+^), and (2) circumventing the issue of unreacted target DNA by directly assembling transpososomes on branched DNA substrates that mimic the strand transfer products ([@bib4]; [@bib32]). Both methods result in an off-pathway pseudo-disintegration reaction that has been referred to as a 'foldback' (see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The foldback products imply that some of the STCs in those experiments were either destabilized prior to the assay itself or not properly assembled to being with. To avoid these issues, we devised a new protocol ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}): STCs are formed by reaction of CDCs with labeled target DNA, but are immobilized on neutravidin-coated magnetic beads via biotinylated Mu end DNAs, such that remaining unreacted labeled target DNA can be rapidly washed away at the end of the STC formation step without stripping the Mg^2+^ ions from the active site. Furthermore, an excess of high-affinity (mismatch-containing) cold competitor target DNA is added in the final wash step to trap any complexes that undergo subsequent disintegration. Any residual unreacted labeled target DNA that was not removed in the washing steps can be quantified by sampling the mixture immediately after purification. Monitoring these purified STCs as a function of time shows that they are impressively robust against disintegration under our normal reaction conditions, with, at most, less than 2% of strand transfer products reverting to re-ligated target DNA after 60 min ([Figure 5A](#fig5){ref-type="fig"}). This is true whether or not DMSO, a mismatch in the target DNA, or domain III were present. Overall, these data suggest that disintegration events themselves are normally rare, regardless of target binding affinity.10.7554/eLife.21777.014Figure 5.Strand Transfer Complex Disintegration.(**A**) Disintegration is not detectable under normal reaction conditions. Substrates and potential products were visualized by denaturing gel electrophoresis and 5'-^32^P-labeled target DNA. STCs were rapidly purified by immobilization on magnetic beads into normal reaction buffer (see Materials and methods), which included DMSO where indicated, and incubated at 30°C. (**B**) Disintegration under modified reaction conditions. The same procedure as in (**A**), but STCs were purified into a modified buffer (see text) and held for 1 hr at the indicated temperatures. Target DNAs in these experiments have 5 bp added to each end to prevent melting during heating. Lanes labeled C are a sample taken immediately after purification, as in the 0 min timepoint in (**A**). (**C**) Quantification of replicates of the experiment shown and described in (**B**). The vertical axis represents the fraction of strand transfer product present immediately after purification that became re-ligated after treatment. Error bars represent mean ± SEM, n = 4 independent STC purifications.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.014](10.7554/eLife.21777.014)10.7554/eLife.21777.015Figure 5---figure supplement 1.Pseudo-disintegration of strand transfer products by the 'foldback' pathway.(**A**) A schematic of foldback disintegration. Mu STCs react to the melting of the 5 bp overlap in the target DNA by catalyzing cleavage of the Mu end-target DNA junctions using a target DNA 3'OH as the nucleophile. The difference between foldback, shown here, and a true reversal of the strand transfer reaction lies in the choice of which target 3'OH is used in the reaction. Although the Mu end DNA products are the same, the target site becomes split into two hairpin ends. (**B**) The sequence of a SinMu end DNA fragment with 10 nt of flanking DNA past the cleavage site (compare to Supplemental [Figure 1A](#fig1){ref-type="fig"}). We find that Mu end DNAs with this extended single stranded flank can trigger foldback disintegration under certain conditions. As in Supplemental [Figure 1A](#fig1){ref-type="fig"}, the nucleophile for strand transfer is shown in bold and red, and protein binding sites are indicated by black and blue arrows. (**C**) A target DNA fragment designed for simple detection of foldback products. The products of foldback disintegration from target DNA fragments where strand transfer occurs approximately in the center of the sequence (as is the case elsewhere in this work) are the same length (once denatured) as the input target DNA fragment, which makes the products of true vs. foldback disintegration difficult to differentiate. The target DNA fragment here uses an off-center mismatched base pair (bold green) to direct strand transfer to positions (red arrows) where it is possible to differentiate the 5'-labeled intact target DNA (45 nt) from strand transfer products (15 and 25 nt) and from foldback products (35 and 55 nt). (**D**) Our disintegration assay does not trigger foldback disintegration. Here, the same protocol as in [Figure 5](#fig5){ref-type="fig"} was used, but the target DNA was that from (**C**) and labeled at both 5' ends, and incubation time was 25 min. The expected strand transfer products are present, but foldback products are not. (**E**) Foldback disintegration is triggered under certain conditions. Here, we used the Mu end DNA described in (**B**) to form reversal-prone (see [Figure 5](#fig5){ref-type="fig"}) Δ domain III strand transfer complexes. Purification of these STCs by gel electrophoresis followed by supplementation of MgCl~2~ and heating for 25 min. using the protocol from ([@bib4]) does trigger foldback disintegration at high temperatures (note the new 35 and 55 nt products in the 60° lane). This demonstrates our ability to detect foldback if it occurs.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.015](10.7554/eLife.21777.015)10.7554/eLife.21777.016Figure 5---figure supplement 2.Method for generating STCs for disintegration experiments.A schematic for the experiments performed in [Figure 5](#fig5){ref-type="fig"}. CDCs are assembled on Mu end DNAs in which the transferred strand is labeled at the 5' end with biotin (see also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Four unpaired thymidine residues separate the biotin label from the Mu end DNA sequence. Magnetic beads coated in Neutravidin (Nav) are present during CDC assembly. Excess MuA and Mu end DNA is then washed away, and replaced by buffer containing Mg^2+^ and the intended ^32^P-labeled target DNA to permit strand transfer to occur. Excess labeled target DNA is then also washed away, the buffer (optionally) exchanged to increase pH and glycerol content, and cold mismatch-bearing target DNA competitor is added. Immediately, a sample is taken to record the baseline level of residual unreacted labeled target DNA, and then samples can be taken to detect disintegration as a function of time and/or incubation temperature.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.016](10.7554/eLife.21777.016)

Previous studies have indicated several factors that could stimulate reversal: increased temperature, increased pH, and higher concentrations of glycerol in the reaction buffer ([@bib4]; [@bib20]). We note that the first two modifications might weaken binding between MuA and bent target DNA. Indeed, we found that the combination of slightly increased buffer pH (7.9 instead of 7.4), increased glycerol content (16% instead of 5%), and high temperatures (60°C) triggered disintegration ([Figure 5B](#fig5){ref-type="fig"}). Under these conditions, WT STCs converted between 10--15% of strand transfer products back into intact target DNA after 1 hr, ([Figure 5C](#fig5){ref-type="fig"}). In our assay, this occurs without producing the 'foldback' products that have complicated previous studies ([Figure 5---figure supplement 1D,E](#fig5s1){ref-type="fig"}). Unlike the forward strand transfer reaction, disintegration was not highly affected by including a mismatch in the target DNA. Remarkably, when subjected to the same buffer and heat challenge, Δ domain III STCs catalyze 4-fold more disintegration than WT STCs, reverting about 40% of strand transfer products back into intact target DNA.

Target DNA bending occurs upon binding but is deficient in Δ domain III CDCs {#s2-4}
----------------------------------------------------------------------------

To observe more directly when the transpososome bends the target DNA and if the bend changes as a result of strand transfer, we measured Förster resonance energy transfer (FRET) between Atto565 and Atto647N fluorescent labels positioned at opposite 5' ends of our 35 bp target DNA. Target DNA bending would bring the labels at each end of the target DNA into closer proximity, reducing the fluorescence intensity and lifetime of the donor Atto565 label. We used time correlated single photon counting (TCSPC) to capture this decrease in donor lifetime. By measuring changes in fluorescence lifetimes, we are able to separate out contributions from unbound/unreacted target DNA and approximate the distribution of lifetimes (and thus the distribution of relative proximities) present in a sample ([Figure 6](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We do this by first observing the behavior of the doubly-labeled target DNA alone, free of any transpososomes ([Figure 6](#fig6){ref-type="fig"}, first column). The 35 bp target DNA should keep the fluorophore pair \>116 Å apart, well outside the 69 Å Forster radius (R~0~) for this dye pair. Indeed, the most reasonable fits to the decay of the DNA-only samples result from fitting a single discrete lifetime (shown as black bars) along with a minor (\<10% of total photons) population of very short lifetimes (shown in grey). We take the former to be the lifetime of the donor fluorophore in unbent DNA (where FRET is negligible), and the latter to be a combination of imperfections in the instrumentation and anomalous fluorophore behavior. Decay measurements taken in the presence of transpososomes were then fit as the sum of this unbound fluorophore lifetime and a gaussian distribution representing any shorter lifetimes resulting from transpososome-induced bending.10.7554/eLife.21777.017Figure 6.Target DNA bending measured by TCSPC FRET.The measured fluorescence decay for each condition was fit with a model combining a discrete lifetime (black bars) and a distribution of lifetimes (colored gaussian distributions). In each plot, the area under each component represents its molar fraction in the fit; the center, full width at half maximum (FWHM) and relative abundance is given for each FRET distribution. In the absence of transpososomes (left-most column), little to no FRET can be detected and the vast majority of fluorophores decay with a discrete lifetime. This discrete lifetime was held constant as CDCs lacking the strand transfer nucleophile (second column) and active CDCs (third column) were added. Δ domain III transpososomes were used for the bottom row. In the fourth column, the STC samples from the bottom two rows were heated to 60°C for 5 min and measured again.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.017](10.7554/eLife.21777.017)10.7554/eLife.21777.018Figure 6---source data 1.Time correlated single photon counting FRET data.TCSPC FRET data are organized into folders by date of collection so that the data can be paired with their proper instrument response function (IRF). For each measurement taken, three files are given: (1). ifx: The raw output data from the Vinci fluorometer control software (2). txt: A tab delimited text representation of the data, first column is time (ns) and the second is photon counts (3). pdf: The output of the lifetime fitting done in the Vinci control software and represented in [Figure 6](#fig6){ref-type="fig"}. Filenames are descriptive of the sample and conditions: WT or D3: Wild-type transpososomes, or SinMu transpososomes lacking domain III on the catalytic subunits. DMSO: Where present, indicates 15% (v/v) DMSO in the buffer. Mismatch: Where present, indicates that the labeled target DNA contained the central G:G base pairing mistmatch. DO or DA: Target DNA was singly labeled with donor Atto565 fluorophore, or labeled with both donor Atto565 and acceptor Atto647N at opposite ends. 60c: Where present, indicates that the sample and vessel were heated to 60 degrees celsius prior to measurement.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.018](10.7554/eLife.21777.018)10.7554/eLife.21777.019Figure 6---figure supplement 1.Fluorescence lifetime fits across all samples.Each sample was fit as the sum of one gaussian and one discrete lifetime. A donor only fluorophore configuration indicates that the Atto647N FRET acceptor fluorophore was omitted from the target DNA. In the case of DNA only and Donor only samples, no variables were held constant. In samples with transpososomes present, the discrete lifetime from the matching DNA-only sample was held constant (and thus has no associated error) in order to account for an unbound/unbent/singly-labeled fraction. FWHM: Full width at half maximum. TCC: target capture complex, CDCs lacking the 3'OH strand transfer nucleophile were used. STC: strand transfer complex, CDCs fully capable of strand transfer were used. α refers to the pre-exponential factor for the decay component. DO, Donor fluorophore only; DA, Donor and Acceptor fluorophores present.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.019](10.7554/eLife.21777.019)

The bend in bound target DNA prior to strand transfer can be measured by utilizing, once again, CDCs lacking the terminal Mu end 3'OH nucleophile for that reaction. Comparing normal conditions to either addition of DMSO or DMSO plus a mismatched base-pair in the target DNA, our analysis indicates that all three show a population of fluorophores in a bent (reduced fluorescence lifetime) configuration ([Figure 6](#fig6){ref-type="fig"}, second column). Once the contribution from unbound or unbent DNA is removed from each, the lifetime distributions from all three are centered at about 3.3 ns. This indicates that bound DNA is bent to approximately the same degree under all conditions and that enhanced flexibility acts largely to increase the bound/bent fraction. That the normal target DNA/normal buffer condition shows a large unbound/unbent fraction is not surprising, given we have shown it exhibits poor affinity and struggles to utilize target DNA to completion. There is some suggestion in the fitted distributions that more flexible DNA is bent more stably, as judged by the tighter widths (FWHM) of the FRET distributions, but this trend may be outside of the resolution of this analysis. If strand transfer is allowed to proceed (by using unmodified Mu end DNAs; [Figure 6](#fig6){ref-type="fig"}, third column), the bend remains nearly unchanged for WT transpososomes across both the normal and highest flexibility conditions. Thus, any conformational changes in the target DNA brought about by strand transfer must be confined mainly to the vicinity of the nicks.

FRET also confirmed that Δ domain III CDCs have a reduced ability to bend target DNA. We have shown that they can bind relatively tightly to target DNA when both DMSO and a mismatched base pair are present ([Figure 3B](#fig3){ref-type="fig"}). However, FRET data for these same complexes indicates very little bending, despite the experiment being carried out at concentrations where the vast majority of the target DNA would be bound. This is direct evidence that our truncated CDCs are bending deficient. However, it is curious that despite a lack of bending they are still able to carry out strand transfer at a rate comparable to WT. It may be that there is a conformation of the target DNA that is competent for strand transfer (and still enhanced to a great degree by a base-pair mismatch) which does not necessarily bring the distant ends of the target DNA closer together, e.g. bends that are not properly phased for a U-turn, or it may be that the mismatch and DMSO allow rapid but very transient sampling of the strand-transfer-competent conformation. Nevertheless, after strand transfer proceeds and opens nicks in the target DNA, we find that the target DNA in Δ domain III STCs becomes significantly more bent and adopts a bend very similar to that seen in WT CDCs and STCs. This suggests that the breaks in the target DNA phosphate backbone allow it to access a bent conformation that is low enough in energy as to be resilient to the loss of some transpososome-DNA contacts. We also note that this convergence on the same bend coincides with the convergence in WT and Δ domain III behavior in resisting disintegration (at normal temperatures).

Finally, to determine whether unbending occurs under the high temperatures that trigger disintegration, we used a Peltier heater built into the cuvette holder of our TCSPC instrument to bring the mismatched target + DMSO STC complex samples rapidly to 60°C for 5 min prior to taking a repeated measurement. Heating the samples resulted in sizeable broadening of the FRET distribution, particularly for the disintegration-prone Δ domain III transpososomes, and an increase in the fitted amount of unbent target DNA ([Figure 6](#fig6){ref-type="fig"}, fourth column). This means that disintegration coincides with conditions where the target DNA conformation is less stably controlled (and a fraction of STCs may have lost the bend in the target DNA entirely).

Discussion {#s3}
==========

In this study, we have shown that the conformation of the target DNA has dramatic consequences for transposition by phage Mu. Our model for this process is shown as a free energy reaction coordinate diagram in [Figure 7A](#fig7){ref-type="fig"}. In the absence of outside factors, newly assembled transpososomes bind to potential target DNA with low affinity. We hypothesize that this is because the target DNA must be strongly bent to optimize its contacts with CDCs, but free energy released by making those contacts does not compensate well for the conformational strain required to bend the target DNA. This is supported by our findings that enhancing the flexibility of the target DNA and pre-bending it both greatly enhance its affinity for CDCs, while removing some of the contacts that stabilize the bent form by deleting domain III greatly reduces its affinity. We also found that strand transfer rates correspond relatively well with target binding affinity, which suggests that getting target DNA into the active sites of the CDCs can be rate-limiting for strand transfer and thus provides a control point for determining the choice of target. This aspect of Mu transposition was exploited by [@bib46] who showed it can be used in vitro to pinpoint a single mismatch in the presence of a vast excess of unperturbed DNA. Furthermore, in vivo transposition into unperturbed target DNA may be even slower than in our assays, as the presence of intact flanking DNA has been shown to further inhibit target capture ([@bib44]).10.7554/eLife.21777.020Figure 7.Bending the target DNA slows target capture and resists disintegration.(**A**) Cartooned as a simplified free energy diagram, with the unmodified system as the bold black line. Target DNA capture is energetically uphill because the target DNA must be bent. This equilibrium can be altered to favor target capture by factors that promote DNA flexibility (here, mismatched base-pairs, DMSO buffer, or mini-circularization, dashed red line), or to make target capture even more uphill by removing some contacts between the transpososome and the target DNA (here, deleting domain III, dashed purple line). Strand transfer interrupts the target DNA backbone, thus releasing the conformational strain induced by the bend while preserving or solidifying the protein-DNA contacts between the transpososome and target. This leaves the strand transfer products in a deep thermodynamic optimum that prevents disintegration. Our results indicate that domain III stabilizes the target DNA conformation to a greater degree after strand transfer. The dashed grey line represents a hypothetical transposase that binds to target DNA favorably and without inducing any conformational strain. (**B**) The features of the energy landscape outlined in (**A**) have the effect of resisting target DNA capture until an outside factor (e.g., MuB) can compensate for the uphill free energy difference. After strand transfer, the release of bending strain combined with product binding energy ensure that strand transfer is effectively irreversible.**DOI:** [http://dx.doi.org/10.7554/eLife.21777.020](10.7554/eLife.21777.020)

Why should transposition be slow by default? Why scan through potential target sites? Although Mu and many of its transposon and retrovirus relatives do not hunt for specific target sequences, they do need to avoid inserting into their own genomes even though their own DNA is necessarily present at high local concentration. We propose that transposition is repressed by default except in the presence of DNA bound by target selection proteins. For Mu, target selection is driven by the distribution of MuB protein, whose reported biochemical activities appear at first glance paradoxical (reviewed in [@bib10]). MuB forms filaments along dsDNA in the presence of ATP ([@bib26]; [@bib28]), and binds the C-terminal region of MuA ([@bib45]). Contact with MuA, even the monomeric form present before a transpososome is formed, triggers ATP hydrolysis and DNA release by MuB ([@bib1]; [@bib14]). Thus DNA near the Mu ends is probably cleared of MuB before an active transpososome is formed. However, MuB-bound DNA molecules are strongly preferred as transposition targets. Until recently, it has been difficult to explain how DNA sites coated or encased in MuB can be attractive targets. Our results suggest how transposition targeting mechanisms might activate transposition: their ability to present pre-deformed or pre-bent DNA. The structural data available for MuB and IstB (the related targeting ATPase from IS21elements) suggest that they have the ability change the helical conformation of the DNA they coat and/or to form bundles of protein-DNA filaments ([@bib3]; [@bib9]; [@bib28]). Loops could be extruded from these large protein-DNA complexes by transient dissociation events within a filament or as the DNA crosses from one collinear filament to an adjacent one within a bundle. These loops could act like our pre-bent minicircles, triggering tight binding and rapid transposition. This is supported by the observation that Mu has a bias towards target sites immediately adjacent to MuB-coated DNA, rather than inside MuB filaments themselves ([@bib13]). For retroviral integration, nucleosomes provide pre-bent DNA by their very nature. Retroviral integration happens directly on the nucleosome, and a high-resolution structure of this event has been obtained by cryo-electron microscopy ([@bib25]). Nucleosome DNA could be a favored target as long as the energy needed to dislodge a DNA loop slightly from the nucleosome surface and into the integrase active sites is less than that required to bend DNA de novo. There is biochemical evidence for this energetic compromise, as integration is known to occur predominantly at positions that are bound least tightly to the histone core ([@bib25]; [@bib40]).

Much of the conformational strain accrued by the bent target DNA could be released by strand transfer nicking the target DNA backbone. These nicks would allow the adjacent DNA to locally relax to a less strained conformation while maintaining or strengthening the energetically favorable MuA-target contacts. Additionally, the structural consequence of relaxing the strain in the bent target DNA could be to eject one or both of the strand transfer product moeities (the target 3'OH or new phosphodiester bond) from the active site, which is the case for the four available strand transfer complex structures ([@bib24]; [@bib33]; [@bib34]; [@bib48]). The equilibrium of the strand transfer reaction may therefore be strongly biased toward products because the final strand transfer complex is much lower in energy than the initial states (CDCs both before and after capturing target DNA).

This thermodynamic minimum may be so deep that thermal energy is insufficient to bring the 3' OH and scissile phosphate group back into reacting position at any appreciable rate. The existence of a kinetic barrier to disintegration is supported by our finding a lack of disintegration products at 30 degrees, even under conditions where we would have expected any transiently-formed disintegrated target DNA dissociate because its affinity for CDCs is so weak: Δ domain III transpososomes with no DMSO, and fully base paired DNA with WT transpososomes and no DMSO (and with an excess of higher affinity cold target DNA present to trap any released CDCs). This implies that under these conditions, the transpososomes simply do not sample the equilibrium between the target capture and strand transfer complexes.

Disintegration could be detected, however, at high temperature, which FRET showed also destabilizes the conformation of the STC target DNA. We suggest that heat weakens the protein-DNA contacts holding the strand transfer product moieties away from the active site and provides the thermal energy necessary to escape the STC energy minimum. Disintegration at 60 degrees was much more efficient for Δ domain III STCs than for WT ones. Because the Δ domain III CDCs have very low affinity for target DNA, this might be explained by their releasing transiently disintegrated DNA more readily. However, WT complexes have a much lower affinity for normal vs. mismatched target DNA, but these produced similar amounts of disintegration product. This suggests instead that domain III -- target DNA interactions have an even stronger stabilizing effect on the final strand transfer complex than they do on the intermediate captured target, probably because the binding surface is particularly tailored to a target DNA conformation that is only readily accessible after nicking. Therefore removal of domain III appears to adjust the equilibrium between the target capture complex and the final STC.

An alternate way to consider the energetics of this reaction is to consider the free energy diagram if there were no DNA bending, or in the most extreme case, no contacts to any part of the DNA except the scissile phosphate. In that case (dashed grey line in [Figure 7A](#fig7){ref-type="fig"}), transpososomes would likely bind to any free DNA immediately as a target and there were be no energetic difference between the target capture complex and the final STC (the equilibrium while bound to the enzyme would be 1). Regarding the strand transfer step, we propose that removing domain III, heat, and the other buffer modifications that helped to promote reversal, move the system slightly toward this scenario by weakening the contacts between the target DNA and MuA. Heat also by definition helps cross the kinetic barrier between the two states (in both directions).

In summary, we find that target DNA is strongly bent upon initial capture by CDCs (as shown by the FRET data in [Figure 6](#fig6){ref-type="fig"}). Because the energy required to induce this bend in the DNA is only partially compensated for by energetically favorable protein-DNA contacts, CDCs have very weak affinity for unperturbed target DNA, which is reflected in very slow rates of strand transfer into those targets. As cartooned in [Figure 7A](#fig7){ref-type="fig"}, we found that this barrier can be overcome in several ways: by lowering the free energy of the bent DNA conformation, using DMSO or a mismatch, or by raising the free energy of the initial unbound state by ligating it into a strained pre-bent minicircle. We suggest that in the natural pathway for Mu transposition, MuB protein does the latter, presenting pre-bent DNA to the CDCs. The affinity for target DNA could be manipulated in the opposite direction by removing domain III. That Δ domain III transpososomes are specifically defective in stabilizing DNA bending was supported by our observation that they could be rescued by increasing the flexibility of the target DNA or by pre-bending it. The strand transfer reaction greatly increases the stability of the final protein-DNA complex by releasing strain in the target DNA while maintaining, and probably increasing, the protein-DNA contacts. The stability of this complex shifts the equilibrium of the strand transfer reaction strongly towards products.

We therefore propose that target DNA bending therefore serves two purposes ([Figure 7B](#fig7){ref-type="fig"}): (1) it helps enforce proper choice by rendering binding of CDCs to naked target DNA very weak, and (2) it alters the energetic landscape in a way that drives the strand transfer reaction forward.

Materials and methods {#s4}
=====================

Expression and purification of MuA and SinMu proteins {#s4-1}
-----------------------------------------------------

Proteins were expressed in the Rosetta DE3 Escherichia Coli strain (Merck KGaA, Darmstadt Germany) from coding sequences cloned into the pET3c plasmid. Transformed cells were grown at 37°C in LB media supplemented with 100 µg/mL ampicillin to OD600 ≈ 0.7, then protein expression was induced by addition of 0.66 mM IPTG and an additional 20 µg/mL ampicillin. At 2 hr after induction, the cells were collected by centrifugation at 8000 rpm, and stored at −80C until lysis. Cells were resuspended in a solution of 25 mM HEPES pH 7.5, 1 mM EDTA, 1 M NaCl, 10% sucrose, 10% glycerol, 5 mM DTT, and Complete protease inhibitor (Roche Diagnostics, Indianapolis IN) and lysed by two passes through an LV1 Microfluidizer (Microfluidics, Westwood MA). Cell debris was removed by centrifugation and the resulting supernatant was fractionated by addition of ammonium sulfate to 30% saturation. The precipitate was collected by centrifugation at 18,000 rpm in an SS-34 (Thermo Fisher Scientific, Waltham MA) rotor for 30 min, and the resulting pellet was resuspended in 20 mM MES pH 5.5, 0.2 M NaCl, 0.5 mM EDTA, 5% glycerol, and 1 mM DTT (Buffer A). This was passed over a HiPrep Heparin FF 16/10 affinity column (GE Healthcare, Chicago IL) and eluted with a gradient from 0.2 M (Buffer A) to 2 M (Buffer B) NaCl. Fractions containing the protein were diluted back into Buffer A and the heparin affinity chromatography was repeated. Fractions containing the protein were concentrated and further purified by gel filtration chromatography using HiLoad 16/600 Superdex 75 prep-grade column (GE Healthcare) equilibrated with 25 mM HEPES pH 7.5, 0.4 M NaCl, 0.5 mM EDTA, 5% glycerol, and 1 mM DTT. Peak fractions were combined, dialyzed into the same buffer supplemented to 20% glycerol, concentrated, and stored at −80°C. The final concentration of proteins was determined by measuring their absorbance at 280 nm.

DNA substrates {#s4-2}
--------------

The sequences of the linear DNA substrates used in this work are given in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. All oligonucleotides, including biotin and fluorophore modifications, were synthesized by Integrated DNA Technologies (IDT, Coralville IA). Oligonucleotides modified with biotin or fluorophores were HPLC purified by IDT, and ^32^P labeled oligonucleotides were PAGE purified by IDT. Oligonucleotides were resuspended in TE (10 mM Tris pH 8, 1 mM EDTA), and those not purified by IDT were desalted using P6 spin columns (Bio-Rad Laboratories, Hercules CA) equilibrated in TE. The concentration of all oligonucleotides was verified by measuring their absorbance at 260 nm. DNA substrates were radiolabeled at the 5' end using γ-^32^P ATP (PerkinElmer, Waltham MA) and T4 polynucleotide kinase (Thermo Fisher Scientific). Oligonucleotides were 3' modified with dideoxy-adenosine by 4 hr treatment with Terminal Transferase (New England Biolabs, [Ipswich MA](https://www.google.com/search?q=Ipswich+Massachusetts&stick=H4sIAAAAAAAAAOPgE-LSz9U3MDKvyMoyV-IEsQ1zzQsqtbSyk63084vSE_MyqxJLMvPzUDhWGamJKYWliUUlqUXFAHZQROBFAAAA&sa=X&ved=0ahUKEwif7aOOtrjSAhVhxFQKHQxnB2oQmxMIgAEoATAS)) and a 25-fold molar excess of dideoxy-ATP. Double stranded DNA substrates were created by mixing complementary oligonucleotides of the desired sequence in equimolar amounts in a buffer of 10 mM Tris pH 8, 100 mM NaCl, and 1 mM EDTA, heating to 80°C, and then slowly cooling to room temperature.

Transposition reactions {#s4-3}
-----------------------

CDCs were formed in a buffer of 25 mM HEPES pH 7.4, 200 mM NaCl, 5% glycerol, 0.6 mM Zwittergent 3--12 (Merck KGaA), and 0.5 mM EDTA. The reaction buffer used during experiments was identical to this, except EDTA was omitted and replaced with 10 mM MgCl~2~. Where indicated, these buffers also contained 15% (v/v) DMSO. Unless otherwise specified, this reaction buffer was used for all experimental procedures involving transpososomes. Cleaved donor complexes (CDCs) were formed by mixing protein and Mu end DNAs in a 2:1 MuA protein:Mu end DNA ratio (or a 1:1:1 MuA protein:SinMu protein:Mu end DNA ratio) and incubating at 30°C for ≥1 hr. In cases where gel filtration was used to purify CDCs, DMSO was included in the formation buffer. Purification of CDCs by gel filtration was performed using a Superdex 200 Increase 10/300 column (GE Healthcare) equilibrated in formation buffer lacking DMSO. After gel filtration the tetramer peak was collected, spin concentrated, quantified by measuring absorbance at 260 nm, and used immediately. Target binding or strand transfer reactions were carried out at 30°C and initiated by diluting fresh CDCs and the appropriate target DNA into reaction buffer. This buffer contained DMSO where indicated. For electrophoretic analysis, strand transfer reactions were stopped by phenol:chloroform extraction.

Fluorescence anisotropy {#s4-4}
-----------------------

CDCs were formed as described above, except with DNAs ending in dideoxy-A and in reaction buffer (with mM MgCl~2~), which was present during all steps. Purified CDCs were serially diluted (in reaction buffer), mixed with 6 nM Atto565-labeled target DNA, and arrayed into a Corning 3575 black polystyrene 384 well microplate (Corning, Corning NY). Binding reactions were incubated for 1 hr at room temperature. A Victor X5 plate reader (PerkinElmer) was used to read the anisotropy of the Atto565 fluorophore, using a 531 nm excitation and 595 nm emission filters and a 1.0 s counting time. The raw parallel and perpendicular photon counts were adjusted to account for the instrument response (G factor and plate positioning artifacts), and the resulting anisotropies were fit to an equilibrium binding model, accounting for receptor depletion, using the optimize.curve_fit function from the Python scipy package (Research Resource Identifier (RRID:[SCR_008058](https://scicrunch.org/resolver/SCR_008058)). For each data point, 15 total measurements of anisotropy were made: three separate serial dilutions each measured by the plate reader five times.

Minicircle DNA {#s4-5}
--------------

Minicircle DNAs were constructed by ligating together two linear DNA fragments with complementary sticky ends. These fragments contained a binding site for the Integration Host Factor (IHF) protein, which was added prior to ligation so that the DNA fragments would be bent in order to encourage circular ligation. IHF protein was purified using a protocol described previously ([@bib42]). The sequences of the minicircle DNAs used in this work are given in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. In detail, the two DNA pieces were mixed in an equimolar ratio along with a twofold molar excess of IHF in T4 Ligase buffer (New England Biolabs) for 30 min at room temperature. T4 DNA Ligase (New England Biolabs) was then added and the mixture incubated for 12 hr at room temperature. Proteins were removed by phenol:chloroform extraction followed by P6 column (Bio-Rad Laboratories) buffer exchange into fresh T4 Ligase buffer. T4 DNA Ligase was added back in and incubated at room temperature for an additional 2 hr to remove any remaining nicks. This reaction mixture was phenol:chloroform extracted and separated by gel electrophoresis on an 8% polyacrylamide TBE gel. The band corresponding to the circular product was identified by UV shadowing, excised, and extracted by shredding the gel slice and soaking in a \~15 fold volume excess of 10 mM Tris pH 8, 250 mM NaCl, and 2 mM EDTA for 8 hr at room temperature. Gel fragments were removed by filtration. To remove any remaining linear fragments or nicked circles, an equal volume of 2x BAL-31 nuclease buffer and 5 µL BAL-31 nuclease (New England Biolabs) were added and incubated for two hours each at 30°C and 40°C. The nuclease was removed by addition of EGTA to 20 mM followed by phenol:chloroform extraction and P6 column buffer exchange into a buffer of 10 mM Tris pH 7.5, 100 mM NaCl, 15% glycerol, 2 mM EDTA, and 2 mM EGTA. Minicircles were stored at −20°C.

Disintegration {#s4-6}
--------------

CDCs were formed as described above using Mu end DNAs modified with biotin on the 5' end of the transferred strand ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). After allowing an hour for CDC formation, Sera-Mag SpeedBeads NeutrAvidin particles (GE Healthcare) were added to \~0.1% (w/v) final concentration and incubated for an additional 30 min at 30°C. Using a magnet to immobilize bead-bound CDCs, the mixture was washed to remove unbound protein and DNA and replace the CDC formation buffer with reaction buffer (including MgCl~2~ and DMSO). An approximately two-fold molar excess of the indicated target DNA was then added for STC formation. This strand transfer reaction proceeded for 2 hr at 30°C, with gentle mixing every 30 min to keep the magnetic beads evenly dispersed. During the final 5 min, heparin was added to a final concentration of 0.05 mg mL^−1^ to encourage dissolution of any incompletely formed MuA-DNA complexes. Immobilized strand transfer complexes were then washed four times into the desired buffer for disintegration (which always contained MgCl~2~). A \~5 fold molar excess of unlabeled cold competitor mismatched target DNA was added in the final wash. A sample was always taken immediately after the final wash (time = 0 min) to record the initial baseline levels of reacted/unreacted DNA. After this, the reaction was either sampled as a function of time or divided equally among three temperature conditions (30°C, 45°C, and 60°C) for 1 hr. Disintegration was carried out where indicated in either the standard reaction buffer used throughout this work, or reaction buffer modified to pH 7.9% and 16% glycerol. Samples of the reaction were taken by dilution into a 10-fold volume excess of 97% formamide +10 mM EDTA that had been pre-heated to 100°C.

Time correlated single photon counting FRET {#s4-7}
-------------------------------------------

Samples included 100 nM of labeled target DNA and either 1.5 µM (for the fully base-paired target DNA / no DMSO condition) or 1.0 µM (all other samples) purified CDCs. This mixture was equilibrated at 30°C for 1 hr prior to measurements. For each condition, measurements were made of both a donor-only (Atto565) and a donor-acceptor (Atto565 + Atto647N) sample. Time-domain lifetimes were measured on a ChronosBH lifetime fluorometer (ISS, Inc., Champaign IL) using Time-Correlated Single Photon Counting (TCSPC) methods. The fluorometer contained Becker-Hickl SPC-130 detection electronics and an HPM-100--40 Hybrid PMT detector (Becker & Hickl GmbH, Berlin Germany). Tunable picosecond pulsed excitation at 565 nm was provided by a Fianium SC400--2 supercontinuum laser source with integrated pulse picker and AOTF (NKT Photonics, Birkerød Denmark). Emission wavelengths were selected with a Semrock Brightline FF01-593/40 bandpass filter (Semrock, Inc., Rochester NY). The Instrument Response Function (IRF) was measured in a 1% scattering solution of Ludox LS colloidal silica in matched buffers. Multi-component exponential decay lifetimes and distributions were fit via a forward convolution method in the Vinci control and analysis software (ISS, Inc.). For both donor only and donor-acceptor samples, all fitted parameters are given in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. Raw data in both the original and a tab-separated plain text format, as well as fitting outputs from the Vinci software in PDF format, are available for download as [Figure 6---source data 1](#SD1-data){ref-type="supplementary-material"}.

Plots were prepared using the Python package Matplotlib (RRID:[SCR_008624](https://scicrunch.org/resolver/SCR_008624)). Visualization and rendering of macromolecular structures for figures used Pymol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC; RRID: [SCR_000305](https://scicrunch.org/resolver/SCR_000305)).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Target DNA bending by the Mu transpososome promotes careful transposition and prevents its reversal\" for consideration by *eLife*. Your article has been favorably evaluated by Michael Marletta (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The three reviewers found your manuscript entitled \'Target DNA bending by the Mu transpososome promotes careful transposition and prevents its reversal\' an interesting and, for the most part, well-written manuscript addressing a central question in the regulation of DNA transposition. The paper shows that bending of the target DNA is a key regulatory step where they isolate target binding and cleavage from the earlier processing steps using an array of biochemical and FRET-based methods. Furthermore, it also presents a convincing model explaining why the Strand Transfer Complex (STC) is so stable that its disassembly requires the action of an ATPase.

Essential revisions:

Overall the conclusion was that the manuscript would benefit from some revision to increase its general accessibility, and to resolve some issues of clarity and mechanism. Below I list the issues that in our opinion need addressing before a decision on publication can be made.

1\) Text and numbers in some of the Figures (e.g. [Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}) are hard to read and the figures are very crowded. Furthermore, there is a range of font sizes and font styles-regular vs. bold. In the second paragraph of the subsection "MuA domain III participates in target DNA binding and bending", \'select conditions\' does not seem right.

2\) Introduction, second paragraph: \"Host-transposon boundary\" is inappropriate. Please re-word (e.g., \'cleavage at specific sites at the transposon ends\'. In the in vitro experiments discussed in this paper, there is no \'host\'.

3\) Subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph: Sentence has been truncated?

4\) Section \"Strand transfer reversal only occurs under conditions that would compromise target DNA binding...\": This section should be substantially rewritten, as we did not find it particularly straightforward to understand, especially for someone who is not familiar with Mu transposition. It would be important to clearly define the two possible assembly methods of the STC and explain why one particular method was chosen here. Please define \"excess components\". Please find some way more conducive to the reproducibility of these experiments to describe STC purification more precisely than \"rapidly and gently\" (subsection "Strand transfer reversal only occurs under conditions that would compromise target DNA binding", first paragraph). I think the lack of a clear description of the different possible assembly methods also shows up at \"unreacted labeled target DNA\" Unreacted at which step? I think it would also be helpful to include a panel in [Figure 5](#fig5){ref-type="fig"} showing exactly the steps in these experiments.

In the second paragraph of the aforementioned subsection: I think it would also be useful to add a few lines pointing out that in the X-ray structure described by Montano et al., the STC was also assembled (like here) from components of Mu ends and target that they reacted after assembly. Please correct us if we are wrong.

5\) A second issue related to target bending/flexibility is the observation that reversal of the strand transfer reaction is normally a rare event. Given that the reaction is overall isoenergetic and disintegration is unimolecular, the mechanistic basis for this has not been clear. We found the authors\' discussion of this phenomenon in terms of their experimental results (Discussion, last paragraph) to be difficult to follow. The idea of \"a deep energetic well out of which the strand transfer products rarely reverse, despite the otherwise enthalpically neutral (and likely entropically uphill) nature of that chemical reaction\" seems to be a thermodynamic argument that the STC product of the reaction has a lower free energy than the pre-cleavage complex. In this scenario, disintegration is energetically uphill because the complex needs to reach a pre-cleavage like configuration in order to reverse the reaction. Wouldn\'t this also imply that bending-compromised complexes would have even more difficulty reversing the reaction since they would be going even more uphill? The other point of confusion here is that the lack of reversal could be primarily a kinetic barrier; this could be what the authors had in mind, but if so it is not clear.

Relating to this, one reviewer was confused by [Figure 7](#fig7){ref-type="fig"}. The figure indicates that the target capture complex (prior to cleavage) has a higher free energy than the reactants, yet the authors demonstrate Kd values of 15-30 nM for this binding event under bending-favored conditions (i.e., std deltaG \<\< 0). It is therefore hard to reconcile the rest of the figure. It seems that one could explain disintegration rates based on the stability of the target capture complex alone. For a stable complex (DMSO, mismatch), disintegration could occur at some rate, but the stability of the disintegration product just promotes target cleavage again and the energy relaxation resulting from nicking (as suggested by the authors) favors the STC. For unstable complexes, disintegration will result in a greater dissociation, giving the net effects observed.

6\) It would be helpful if the authors included a figure similar in content to that of [Figure 2A](#fig2){ref-type="fig"}, Montano et al. Nature 491, page 414. This is because as it is now, [Figure 1B](#fig1){ref-type="fig"} doesn\'t allow a clear understanding of either the significance of domain III or that of the SinMu chimera. Given that the comparison with the other target-containing transposomes is important; this additional figure should be a new panel somewhere. The best place to reference such a figure (or panel) would probably be somewhere in the first paragraph of the subsection "MuA domain III participates in target DNA binding and bending".

7\) In the Introduction, the passage "Transposases and integrases face two challenges when interacting with target DNA sites...": the authors should consider rewriting this, as we are not aware that target immunity has been shown to be a general feature of transposition. In fact, there may be more DNA transposons that do not care about inserting into themselves.

8\) Introduction, third paragraph: along these lines, please replace \"many\" with \"some\".

9\) Subsection "Flexible or bent DNA is a highly reactive transposition target", fifth paragraph, and in other instances when \"transpososomes\" are mentioned: I think, for clarity, it would be very useful to specify whether we are talking about the CDC or the STC in all cases through the manuscript.

10\) Subsection "MuA domain III participates in target DNA binding and bending", second paragraph: \"virtually required\" Please rephrase; what is a \'virtual requirement\'?

11\) Discussion, second paragraph: \"We propose...\". I think this sentence is perhaps the most important conclusion in the work, and the arguments that follow put the in vitro data in the manuscript into a biological context. I think that more effort should be spent shedding light onto the seeming paradox: MuB-coated DNA mediates immunity, but in the same time it delivers target by pre-bending it. I do not believe that the Discussion, as written now, is sufficient to explain to the uninitiated the relationships between concepts such as \"avoid self-insertion\", \"MuB filaments\" (why are these relevant?) and the role of MuB in target delivery.

12\) [Figure 1A](#fig1){ref-type="fig"}: Show that the second step is reversible (with arrow) and annotate as disintegration.

13)Subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph: Not very clear; please reword or add the idea of \"pre-cleaved transposon ends\" for general readers.

14\) The N-terminal domain that is left out is assumed to not be relevant for the binding/bending questions being addressed. What is the evidence for this assumption?

15\) The G-G mismatch-containing targets used were based on earlier work in the Mu field. Do small bulges work in this system as well? That would seem to be an ideal way to direct and stabilize a bend.

16\) [Figure 2](#fig2){ref-type="fig"}: The experiments shown here do not distinguish between single and double target cleavage events. The authors should identify experiments where this is the case and discuss whether it impacts the conclusions.

17\) [Figure 5](#fig5){ref-type="fig"}: Nothing is happening as a function of time in this experiment. What is the point?

18\) It might be worth pointing out that the overall Mu reaction does ultimately get driven by input of external energy. The stability of the initial complexes formed comes with the cost of needing to hydrolyze ATP (by ClpXP) to take the thing apart at the end. Not tightly coupled, but perhaps worth noting in the context of energetic arguments about the course of the overall reaction.
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Author response

*Essential revisions:*

*Overall the conclusion was that the manuscript would benefit from some revision to increase its general accessibility, and to resolve some issues of clarity and mechanism. Below I list the issues that in our opinion need addressing before a decision on publication can be made.*

1\) Text and numbers in some of the Figures (e.g. [Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}) are hard to read and the figures are very crowded. Furthermore, there is a range of font sizes and font styles-regular vs. bold.

We have made small positional changes in the layout of panels in these Figures to alleviate crowding, although they were designed to visually summarize a large quantity of information.

Throughout the figures, font size is standardized to 8 point Arial in all cases except in which this would make secondary text too large to fulfill its purpose (e.g., size labels for DNA ladders or gel lane labels), in which case the font size is 7 point. For graphs, axis labels are bolded; similarly, for gel images, conditions that are consistent across many lanes or the entire sub-image are bolded. All other text has no style applied. This is broadly consistent with what we see in other articles published in *eLife*. That being said, we are happy to accommodate any additional, specific stylistic suggestions for improving the clarity of our figures.

It is also possible that the conversion to raster.png format, embedding in Word, and subsequent PDF conversion for preliminary submission may have degraded image quality. We expect that the final product generated by *eLife* from our full-resolution vector graphics files will appear easier on the eyes.

In the second paragraph of the subsection "MuA domain III participates in target DNA binding and bending", \'select conditions\' does not seem right.

We have replaced "select" with "particular" to avoid confusion.

*2) Introduction, second paragraph: \"Host-transposon boundary\" is inappropriate. Please re-word (e.g., \'cleavage at specific sites at the transposon ends\'. In the* in vitro *experiments discussed in this paper, there is no \'host\'.*

We have reworded this to clarify exactly where the cleavage occurs, and have made sure that we refer to this segment of DNA in all our experiments as "flank" rather than "flanking host". However, we would like to retain the reference to "host" DNA in this introductory paragraph, as here we are discussing the full in vivo transposition process of phage Mu.

In response to this and other reviewer comments, [Figure 1A](#fig1){ref-type="fig"} has been modified to further emphasize that it refers to the full in vivo system by the addition of a cartoon of an entire host genome. In addition, the fact that our in vitro components are pre-cleaved only have 3 nt of flanking DNA is now more clearly stated in the opening paragraph of the Results section.

*3) Subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph: Sentence has been truncated?*

Correct, we apologize for this error. The fix helps address part 13 below.

*4) Section \"Strand transfer reversal only occurs under conditions that would compromise target DNA binding\": This section should be substantially rewritten, as we did not find it particularly straightforward to understand, especially for someone who is not familiar with Mu transposition. It would be important to clearly define the two possible assembly methods of the STC and explain why one particular method was chosen here. Please define \"excess components\". Please find some way more conducive to the reproducibility of these experiments to describe STC purification more precisely than \"rapidly and gently\" (subsection "Strand transfer reversal only occurs under conditions that would compromise target DNA binding", first paragraph). I think the lack of a clear description of the different possible assembly methods also shows up at \"unreacted labeled target DNA\" Unreacted at which step? I think it would also be helpful to include a panel in [Figure 5](#fig5){ref-type="fig"} showing exactly the steps in these experiments.*

We apologize for the confusion in this section. We have rewritten the entire section for clarity, and added a cartoon of our method ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). We hope it is now clearer that here we *avoid* the STC purification methods used in the two previously published works because they generate the problematic "foldback" side product. We find that using magnetic beads to purify the STC (which, to our knowledge, is an approach to this problem that had previously not been tried) retains their activity and avoids foldback while allowing them to be purified in their normal buffer solution in a matter of minutes -- hence "rapidly and gently". Nevertheless, we have removed those adverbs from the text to avoid confusion.

*In the second paragraph of the aforementioned subsection: I think it would also be useful to add a few lines pointing out that in the X-ray structure described by Montano et al., the STC was also assembled (like here) from components of Mu ends and target that they reacted after assembly. Please correct us if we are wrong.*

We have added a note about how the STCs for crystallization were assembled (it was similar to that used by the Harshey group \[Au et al., 2004\], but without the gel purification) (the added reference can be found in subsection "Strand transfer reversal only occurs under conditions that would compromise target DNA 234 binding", second paragraph). Here we did assemble STCs from components that reacted in situ rather than from branched "product" DNAs, but in this work we preformed CDCs on magnetic beads and washed away excess MuA and Mu end DNAs before adding target DNA and Mg^2+^. This separation of the assembly of CDCs from target DNA capture and strand transfer was not done for crystallization or by Au et al.

*5) A second issue related to target bending/flexibility is the observation that reversal of the strand transfer reaction is normally a rare event. Given that the reaction is overall isoenergetic and disintegration is unimolecular, the mechanistic basis for this has not been clear. We found the authors\' discussion of this phenomenon in terms of their experimental results (Discussion, last paragraph) to be difficult to follow. The idea of \"a deep energetic well out of which the strand transfer products rarely reverse, despite the otherwise enthalpically neutral (and likely entropically uphill) nature of that chemical reaction\" seems to be a thermodynamic argument that the STC product of the reaction has a lower free energy than the pre-cleavage complex. In this scenario, disintegration is energetically uphill because the complex needs to reach a pre-cleavage like configuration in order to reverse the reaction. Wouldn\'t this also imply that bending-compromised complexes would have even more difficulty reversing the reaction since they would be going even more uphill? The other point of confusion here is that the lack of reversal could be primarily a kinetic barrier; this could be what the authors had in mind, but if so it is not clear.*

In retrospect, we agree that the way we framed the role of DNA bending was confusing. We have rewritten most of the Discussion and revised the cartoon in [Figure 7](#fig7){ref-type="fig"} to clarify our ideas.

Briefly, we think that the equilibrium difference in the free energy of the intermediate (target capture) and final (strand transfer complexes) generates, via the "depth" of the strand transfer complex's energy minimum, what is effectively (as the reviewer rightly points out) a kinetic barrier to disintegration (see Discussion, fourth paragraph). We believe our data support this sort of barrier, as opposed to a more "level" energy landcape where the CDC+target DNA and STC are of similar free energies but separated by a very high energy transition state that is unlikely to be crossed.

Similarly to the other reviewer comment addressing disintegration below, we too had considered that Δ domain III STCs might disintegrate at a rate comparable to the WT when heated, if domain III had a *uniform* negative impact on the stability throughout target catpure and after strand transfer. However the data showed that this was not the case. While domain III stabilizes both complexes, because Δ domain III STCs disintegrate at a higher rate it must be that domain III has an even greater stabilizing effect on the STC than during target capture by the CDC. We hope this is better reflected in the new [Figure 7](#fig7){ref-type="fig"} and the new portion of the Discussion that describes it (see Discussion, fifth paragraph).

*Relating to this, one reviewer was confused by [Figure 7](#fig7){ref-type="fig"}. The figure indicates that the target capture complex (prior to cleavage) has a higher free energy than the reactants, yet the authors demonstrate Kd values of 15-30 nM for this binding event under bending-favored conditions (i.e., std deltaG \<\< 0). It is therefore hard to reconcile the rest of the figure.*

The main black line in [Figure 7](#fig7){ref-type="fig"} was meant to reflect the normal behavior of the system without our in vitro DNA flexibility modifications. We observe very poor binding and reaction rates under these conditions, hence the uphill nature of target DNA capture. The dashed purple line, which was labeled with our in vitro modifications, removes the uphill aspect for this very reason. We have now redrawn the entirety of [Figure 7](#fig7){ref-type="fig"} to address other comments while hopefully emphasizing these features.

*It seems that one could explain disintegration rates based on the stability of the target capture complex alone. For a stable complex (DMSO, mismatch), disintegration could occur at some rate, but the stability of the disintegration product just promotes target cleavage again and the energy relaxation resulting from nicking (as suggested by the authors) favors the STC. For unstable complexes, disintegration will result in a greater dissociation, giving the net effects observed.*

Prior to conducting these experiments, we had considered this as a possible result of the reversal experiments (see also our answer to point \#5 above). The data did not end up supporting this idea, however: ([@bib1]) In [Figure 5A](#fig5){ref-type="fig"}, under normal temperature conditions, we observe no disintegration even in the case of removing DMSO from Δ domain III transpososomes, which renders the affinity of those CDCs for target DNA so poor that it is undetectable. This is now noted in the last paragraph of the Results subsection "Strand transfer reversal only occurs under conditions that would compromise target DNA binding" and in the fourth paragraph of the rewritten Discussion section. ([@bib2]) Even under high temperature conditions where we are able to reliably see disintegration events, within WT STCs there is very little difference between mismatched target DNA (which has high target capture affinity) and fully base paired target DNA (which has nearly undetectable target capture affinity). We hope that our rewritten Discussion clarifies these points (fifth paragraph).

*6) It would be helpful if the authors included a figure similar in content to that of [Figure 2A](#fig2){ref-type="fig"}, Montano et al. Nature 491, page 414. This is because as it is now, [Figure 1B](#fig1){ref-type="fig"} doesn\'t allow a clear understanding of either the significance of domain III or that of the SinMu chimera. Given that the comparison with the other target-containing transposomes is important; this additional figure should be a new panel somewhere. The best place to reference such a figure (or panel) would probably be somewhere in the first paragraph of the subsection "MuA domain III participates in target DNA binding and bending".*

We agree that the reader should be made better aware of the structural context of domain III. To this end, we have replaced [Figure 4](#fig4){ref-type="fig"} panel A with an annotated zoomed view of the MuA STC crystal structure. What used to be panel A in that Figure now appears as a supplemental panel under [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. As suggested, we reference this new panel when domain III is first mentioned in the Results subsection "MuA domain III participates in target DNA binding and bending".

*7) In the Introduction, the passage "Transposases and integrases face two challenges when interacting with target DNA sites...": the authors should consider rewriting this, as we are not aware that target immunity has been shown to be a general feature of transposition. In fact, there may be more DNA transposons that do not care about inserting into themselves.*

*8) Introduction, third paragraph: along these lines, please replace \"many\" with \"some\".*

Thank you for pointing this out; we have altered the language (Introduction, third paragraph) accordingly. This is in fact an interesting point (how do DDE transposons without target immunity resolve these detrimental products?), although outside the scope of our work here.

In addition, we have made a small addition to the preceding sentence to further clarify that avoiding self-insertion is required for *successful* transposition, rather than a pitfall that all DDE transposition systems have been shown to avoid. We hope that this makes it clearer that there is a considerable advantage to avoiding self-insertion while not making the claim that this has been shown in all Mu-like transposons.

*9) Subsection "Flexible or bent DNA is a highly reactive transposition target", fifth paragraph, and in other instances when \"transpososomes\" are mentioned: I think, for clarity, it would be very useful to specify whether we are talking about the CDC or the STC in all cases through the manuscript.*

We agree that using the specific acronyms enhances clarity, and have made this change throughout the text. There are remaining instances where we use "transpososomes" to mean all forms of the complex more generally.

*10) Subsection "MuA domain III participates in target DNA binding and bending", second paragraph: \"virtually required\" Please rephrase; what is a \'virtual requirement\'?*

We have changed "virtually required" to "nearly essential" to clarify.

*11) Discussion, second paragraph: \"We propose...\". I think this sentence is perhaps the most important conclusion in the work, and the arguments that follow put the in vitro data in the manuscript into a biological context. I think that more effort should be spent shedding light onto the seeming paradox: MuB-coated DNA mediates immunity, but in the same time it delivers target by pre-bending it. I do not believe that the Discussion, as written now, is sufficient to explain to the uninitiated the relationships between concepts such as \"avoid self-insertion\", \"MuB filaments\" (why are these relevant?) and the role of MuB in target delivery.*

We have completely rewritten this portion of the discussion to better introduce what is known about MuB and to better explain our ideas of how it works.

*12) [Figure 1A](#fig1){ref-type="fig"}: Show that the second step is reversible (with arrow) and annotate as disintegration.*

We have changed [Figure 1](#fig1){ref-type="fig"} to include a small arrow flanked by question marks in order to mark where the disintegration reaction fits in the cartoon and prime a reader to consider the reversibility of this step.

*13) Subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph: Not very clear; please reword or add the idea of \"pre-cleaved transposon ends\" for general readers.*

Those lines (subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph) have been re-worded and (we hope) are now more broadly accessible.

*14) The N-terminal domain that is left out is assumed to not be relevant for the binding/bending questions being addressed. What is the evidence for this assumption?*

The role of domain Iα in Mu transposition has been extensively studied. Domain Iα is a site-specific DNA binding domain whose binding site is known: an "enhancer" region in the Mu genome where binding guides transpososome assembly; whereas (as we discuss in the Introduction section) Mu target selection has relatively little regard for sequence. Furthermore, in the crystal structure of the Mu STC it seems unlikely that domain Iα, at the N-terminus of MuA, would be physically capable of reaching the target DNA at all, as the closest approach of the N-terminus of domain Iβ to the target DNA is 55Å.

In the hopes of guiding the curious reader, we have added an additional citation to this section -- Mizuuchi and Mizuuchi, 1989, (subsection "Flexible or bent DNA is a highly reactive transposition target", first paragraph) -- where the role of this domain was first characterized. For additional clarity, we have also made it explicit in the text that it is site-specific.

Finally, domain Iα is not conserved in related transposases such as those of Tn7 and IS21. We verified this by submitting their sequences to the RaptorX modeling server. RaptorX chooses the Mu transposase structure (which begins with domain Iβ) as the best template from the entire PDB for most of the Tn7 sequence except for its N-terminal \~60 residues, which it models on a template that is structurally unrelated to MuA's domain Iα. For IS21 transposase, RaptorX predicts that the first 24 amino acids are poorly ordered and begins matching that sequence to MuA's domain Iβ at about residue 25.

*15) The G-G mismatch-containing targets used were based on earlier work in the Mu field. Do small bulges work in this system as well? That would seem to be an ideal way to direct and stabilize a bend.*

Early on in the development of this project, attempts were made to explore the consequences of bulges. We had envisioned them as an alternative way to promote disintegration, with the extra nucleotides allowing the target 3'OH to easily access the active site even in a bent state. We found, however, that they were not proficient in directing the bend (like a mismatch) -- instead they resulted in a difficult-to-interpret ladder of products indicating strand transfer at many positions. As a result, we did not pursue the idea further.

*16) [Figure 2](#fig2){ref-type="fig"}: The experiments shown here do not distinguish between single and double target cleavage events. The authors should identify experiments where this is the case and discuss whether it impacts the conclusions.*

We have now tested this using hairpinned target DNA substrates, and found that the vast majority of our strand transfer products (94-98%) reflect double target cleavage events. This new data is added as [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}.

*17) [Figure 5](#fig5){ref-type="fig"}: Nothing is happening as a function of time in this experiment. What is the point?*

We apologize for the confusion on this. Although [Figure 5A](#fig5){ref-type="fig"} is, in a sense, a "negative result," we feel that it is surprising and notable enough to include as a main figure. First, as stated throughout the text, if protein-DNA product binding energy is discounted, disintegration would be expected to occur robustly rather than (as we find) not-at-all. Second, it addresses a discrepancy in the existing literature about the rate at which Mu STCs will catalyze this reaction. We hope that our significant edits to the first paragraph of the disintegration section (in response to reviewer points 4 and 5 above) now make it more clear why this negative result is important to highlight.

We have also changed the legend to [Figure 5A](#fig5){ref-type="fig"} to state the absence of disintegration explicitly.

*18) It might be worth pointing out that the overall Mu reaction does ultimately get driven by input of external energy. The stability of the initial complexes formed comes with the cost of needing to hydrolyze ATP (by ClpXP) to take the thing apart at the end. Not tightly coupled, but perhaps worth noting in the context of energetic arguments about the course of the overall reaction.*

We have edited the second paragraph of the Introduction to better explain this and have added a new reference to the Baker lab's work on ClpX for the curious reader.
